Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Kaplan-Meier Curves and Survival Table for the End Point of TLR to 1,080 Days
In patients treated with the Cypher stent (Cordis), freedom from target lesion revascularization (TLR) remains significantly better than vascular brachytherapy throughout the 3-year follow-up period (log-rank p = 0.018).
|
